Skip to main content
Caplight Logo









Coherence Neuro

Coherence Neuro

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.coherenceneuro.com/

Last Round

Seed

Nov 4, 2025

Est. Valuation

$40M

Total Funding Raised

$16.92M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Coherence Neuro is a medical technology company that designs therapeutic neurotechnology to manage cancer from inside the body.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Medical AI, Clinical Trials, Health IoT

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

brain-computer interfaceBCIcancer treatmentimplantable medical deviceglioblastoma treatmentbrain implantbioelectronic medicineneurotechnologyneuromodulationclosed-loop therapyelectroceuticalstumor treating fieldsprecision medicinesoftware as a therapydigital therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Coherence Neuro Comparables

Compare Coherence Neuro with similar companies based on industry and business-model similarity.

Coherence Neuro comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
QV Bioelectronics
82%
Autem Therapeutics
76%
EMulate Therapeutics
73%

Coherence Neuro Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 4, 2025
Pre SeedApr 28, 2023
Pre SeedMar 13, 2023
GrantAug 3, 2022

Key People

Founding team and executive leadership

Ben Woodington

CEO Co-Founder

Founding Team

Coherence Neuro Investors

Notable investors and investment history

Coherence Neuro investors
InvestorRounds
Spacewalk VCSeed
Xtal VenturesSeed
ArtesianSeed
Cancer Research UKGrant
SmartGateVCSeed
Possible VenturesSeed, Pre Seed
Jumpspace VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 29, 2026

    Grew 19% QoQ, from 26 to 31 employees.

  • May 5, 2026

    Grew 24% QoQ, from 21 to 26 employees.

Recent news

Latest coverage and updates

  • is_developingJun 26, 2026

    Coherence is developing coin-sized brain implant.

Coherence Neuro Filings

Explore SEC and related filing metadata, where available.

Coherence Neuro filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Coherence Neuro's valuation, stock price, and market status.

Is Coherence Neuro a public or private company?

Coherence Neuro is a private company.

What is the current stock price of Coherence Neuro?

Coherence Neuro is a private company with no public stock price. No recent secondary market data is available.

How much is Coherence Neuro worth (valuation)?

Valuation information for Coherence Neuro is not publicly available.

Can I buy Coherence Neuro stock?

Coherence Neuro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Coherence Neuro's last funding round?

Coherence Neuro's most recent funding round was Seed on November 4, 2025.

Who are the main investors in Coherence Neuro?

Key investors in Coherence Neuro include Blackbird Ventures, Topology Ventures.

Will Coherence Neuro IPO soon?

No public IPO plans have been announced for Coherence Neuro.

How can I track Coherence Neuro secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Coherence Neuro's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range23
Year Founded2022
Last FundingNov 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?